• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用双特异性双抗体进行补体募集。

Complement recruitment using bispecific diabodies.

作者信息

Kontermann R E, Wing M G, Winter G

机构信息

MRC Centre for Protein Engineering, Cambridge, UK.

出版信息

Nat Biotechnol. 1997 Jul;15(7):629-31. doi: 10.1038/nbt0797-629.

DOI:10.1038/nbt0797-629
PMID:9219263
Abstract

We describe the engineering of antibody fragments produced in bacteria for recruitment of complement effector functions. From a phage display repertoire we isolated human antibody fragments directed against complement C1q, and linked these to lysozyme-specific antibody fragments, creating bispecific antibodies (diabodies). One diabody was able to recruit C1q, resulting in efficient lysis of lysozyme-coated sheep erythrocytes, and also induced rosette-formation of erythrocytes with human monocytes and phagocytosis after phorbol ester stimulation. These diabodies may have therapeutic applications requiring the activation of complement.

摘要

我们描述了在细菌中产生的用于募集补体效应功能的抗体片段的工程化。从噬菌体展示文库中,我们分离出针对补体C1q的人源抗体片段,并将这些片段与溶菌酶特异性抗体片段相连,从而产生双特异性抗体(双体)。一种双体能够募集C1q,导致溶菌酶包被的绵羊红细胞有效裂解,并且在佛波酯刺激后还能诱导红细胞与人类单核细胞形成玫瑰花结以及吞噬作用。这些双体可能在需要激活补体的治疗应用中发挥作用。

相似文献

1
Complement recruitment using bispecific diabodies.使用双特异性双抗体进行补体募集。
Nat Biotechnol. 1997 Jul;15(7):629-31. doi: 10.1038/nbt0797-629.
2
Retargeting serum immunoglobulin with bispecific diabodies.利用双特异性双抗体重新靶向血清免疫球蛋白。
Nat Biotechnol. 1997 Jul;15(7):632-6. doi: 10.1038/nbt0797-632.
3
Phage diabody repertoires for selection of large numbers of bispecific antibody fragments.用于筛选大量双特异性抗体片段的噬菌体双体文库。
Nat Biotechnol. 1996 Sep;14(9):1149-54. doi: 10.1038/nbt0996-1149.
4
Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.用于肿瘤治疗的双特异性串联双体,具有改善的抗原结合能力和药代动力学特性。
J Mol Biol. 1999 Oct 15;293(1):41-56. doi: 10.1006/jmbi.1999.3156.
5
Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.源自阻断CD80/CD86-CD28共刺激途径的抗体的单特异性和双特异性重组抗体片段的表达与纯化。
Protein Expr Purif. 2001 Jun;22(1):11-24. doi: 10.1006/prep.2001.1417.
6
Current perspectives of bispecific antibody-based immunotherapy.基于双特异性抗体的免疫疗法的当前观点。
J Biol Regul Homeost Agents. 2000 Jul-Sep;14(3):175-81.
7
Comparison of monocyte and complement mediated haemolysis of human A1 erythrocytes: the relationship between antibody, target and effector concentrations in the induction of lysis.人A1红细胞单核细胞介导与补体介导溶血的比较:溶血诱导中抗体、靶标和效应物浓度之间的关系
J Clin Lab Immunol. 1988 Feb;25(2):53-8.
8
Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model.在体外模型中,通过双特异性单克隆抗体与灵长类红细胞补体受体结合的大肠杆菌被转移至人单核细胞并被其吞噬。
J Immunol. 1998 May 15;160(10):5088-97.
9
Recombinant bispecific antibodies for the targeting of adenoviruses to CEA-expressing tumour cells: a comparative analysis of bacterially expressed single-chain diabody and tandem scFv.用于将腺病毒靶向表达癌胚抗原(CEA)的肿瘤细胞的重组双特异性抗体:细菌表达的单链双抗体和串联单链抗体片段的比较分析
J Gene Med. 2004 Jun;6(6):642-51. doi: 10.1002/jgm.555.
10
Protective effects of various compounds on lysis of antibody-coated sheep erythrocytes by hypotonic shock or complement.各种化合物对低渗休克或补体介导的抗体包被绵羊红细胞裂解的保护作用。
Methods Find Exp Clin Pharmacol. 1984 Jun;6(6):287-92.

引用本文的文献

1
Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments.解锁补体依赖性细胞毒性的潜力:用于癌症治疗的有效治疗性抗体开发的工程策略。
BioDrugs. 2023 Sep;37(5):637-648. doi: 10.1007/s40259-023-00618-1. Epub 2023 Jul 24.
2
A novel bispecific antibody platform to direct complement activity for efficient lysis of target cells.一种新型双特异性抗体平台,可定向调节补体活性,从而有效裂解靶细胞。
Sci Rep. 2019 Aug 19;9(1):12031. doi: 10.1038/s41598-019-48461-1.
3
FHR4-based immunoconjugates direct complement-dependent cytotoxicity and phagocytosis towards HER2-positive cancer cells.
基于 FHR4 的免疫偶联物针对 HER2 阳性癌细胞诱导补体依赖性细胞毒性和吞噬作用。
Mol Oncol. 2019 Dec;13(12):2531-2553. doi: 10.1002/1878-0261.12554. Epub 2019 Sep 30.
4
Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.C1 的结构与激活,该复合物启动补体级联的经典途径。
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):986-991. doi: 10.1073/pnas.1616998114. Epub 2017 Jan 19.
5
The making of bispecific antibodies.双特异性抗体的制备。
MAbs. 2017 Feb/Mar;9(2):182-212. doi: 10.1080/19420862.2016.1268307.
6
TriFabs--Trivalent IgG-Shaped Bispecific Antibody Derivatives: Design, Generation, Characterization and Application for Targeted Payload Delivery.三价IgG形状双特异性抗体衍生物(TriFabs):靶向载荷递送的设计、生成、表征及应用
Int J Mol Sci. 2015 Nov 17;16(11):27497-507. doi: 10.3390/ijms161126037.
7
A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.一种新型糖基工程化双特异性抗体形式,用于靶向抑制表皮生长因子受体(EGFR)和I型胰岛素样生长因子受体(IGF-1R),具有独特的分子特性。
J Biol Chem. 2014 Jul 4;289(27):18693-706. doi: 10.1074/jbc.M113.528109. Epub 2014 May 19.
8
scFv antibody: principles and clinical application.单链抗体片段:原理与临床应用
Clin Dev Immunol. 2012;2012:980250. doi: 10.1155/2012/980250. Epub 2012 Mar 15.
9
Oligomeric forms of single chain immunoglobulin (scIgG).单链免疫球蛋白 (scIgG) 的寡聚形式。
MAbs. 2010 Jan-Feb;2(1):73-6. doi: 10.4161/mabs.2.1.10784. Epub 2010 Jan 26.